Across TCGA pan-cancer cohorts, RNU6-316P Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated RNU6-316P data layer compared with 20 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RNU6-316P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-316P expression acts as an unfavorable survival marker.

UCEC are the cancer types where RNU6-316P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	All	0.231	0.873	.004	24	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: RNU6-316P tumor-vs-normal RNA expression · all RNU6-316P data types